RxDoctor Payments Data

Dylan Carlisle

Podiatrist · Mauldin, SCNPI 1518426295

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 29.9% of the total.

$2,015in general payments, 2019–2025

Across 78 payments — averaging $25.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$603
  • Stryker$549
  • Amgen$191
  • Treace Medical Concepts, Inc.$169
  • Medtronic$73
  • Organogenesis Inc.$72
  • plus $359 from 10 others

What the payments were for

  • Food & beverage$2,015100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,015 in reported general payments places this provider in the 65th percentile of 61 podiatrist providers in South Carolina.

See all podiatrist providers in South Carolina

Medicare billing

Part B allowed, 2024
$218,168
Medicare patients
908
Services billed
4,069

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole65$2,065
Ammonium Lactate90$1,905
Ciclopirox55$1,059
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort19$1,050
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$630
Doxycycline Hyclate27$231
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha16$162
Terbinafine Hcl19$148
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$101
Meloxicam15$21

Paid to pharmacies, not to this prescriber.

Other podiatrist in Mauldin

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →